VIT
VITURA FPO [VIT]
Healthcare · ASX Small Cap
$0.0400 +2.6%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical71
Catalyst53
Sentiment50
Fundamental93
Momentum34
Risk Gate45
Get alerts when VIT's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Bollinger Bands are tightening — volatility is coiling up for a potential breakout
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Cash positive / operating cashflow positive
- Low P/S ratio (0.2x)
- Moderate revenue growth (+8%)
- Near 52-week low (4% of range)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (34%)
- Turned profitable (NPAT positive from results)
- Sentiment is mixed — no strong consensus either way
- Low-priced stock risk ($0.040)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 35% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-2.61%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about VIT
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Cortexa advances commercialisation of MDMA supply
NONE VIT enters distribution agreement with MedReleaf Australia
NONE Notification of cessation of securities - VIT
LOW H1 FY26 Investor Presentation
Announcement tone +3pts
Recent ASX Announcements
| 2026-03-22 | Cortexa advances commercialisation of MDMA supply |
| 2026-03-16 | VIT enters distribution agreement with MedReleaf Australia PRICE SENSITIVE |
| 2026-03-12 | Notification of cessation of securities - VIT |
| 2026-02-25 | H1 FY26 Investor Presentation PRICE SENSITIVE |
| 2026-02-25 | H1 FY26 Results Release PRICE SENSITIVE |
Key Metrics
$26.5M
Market Cap
489K
Avg Volume
0.4x
Vol Ratio
$0.04 — $0.08
52-Week Range
N/A
Short Interest
N/A
Cash Runway
1.2%
ROE
0.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 34% |
| L | Leader vs Laggard | laggard | RS: -7 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #44 of 117 · Sector avg: 46
View all Healthcare signals →Track VIT and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required